Item 1. Financial Statements
Item
1. Financial Statements.
Barfresh
Food Group Inc.
Condensed
Consolidated Balance Sheets
September 30,
December 31,
2024
2023
(unaudited)
(audited)
Assets
Current assets:
Cash
$ 401,000
$ 1,891,000
Trade accounts receivable, net
1,663,000
821,000
Other receivables
30,000
160,000
Inventory, net
770,000
1,214,000
Prepaid expenses and other current assets
226,000
67,000
Total current assets
3,090,000
4,153,000
Property, plant and equipment, net of depreciation
390,000
409,000
Intangible assets, net of amortization
194,000
241,000
Other non-current assets
98,000
7,000
Total assets
$ 3,772,000
$ 4,810,000
Liabilities and Stockholders’ Equity
Current liabilities:
Line of credit, net
$ 86,000
$ -
Accounts payable
1,220,000
1,670,000
Disputed co-manufacturer accounts payable (Note 4)
499,000
499,000
Accrued expenses
270,000
85,000
Accrued payroll and employee related
48,000
53,000
Financing agreements - current
95,000
-
Total current liabilities
2,218,000
2,307,000
Financing agreements
151,000
-
Total liabilities
2,369,000
2,307,000
Commitments and contingencies
-
-
Stockholders’ equity:
Preferred stock, $ 0.000001 par value, 400,000 shares authorized, none issued or outstanding
-
-
Common stock, $ 0.000001 par value; 23,000,000 shares authorized; 14,746,172 and 14,420,105 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively
-
-
Additional paid in capital
64,172,000
63,299,000
Accumulated deficit
( 62,769,000 )
( 60,796,000 )
Total stockholders’ equity
1,403,000
2,503,000
Total liabilities and stockholders’ equity
$ 3,772,000
$ 4,810,000
See
the accompanying notes to the condensed consolidated financial statements
3
Barfresh
Food Group Inc.
Condensed
Consolidated Statements of Operations
For
the three and nine months ended September 30, 2024 and 2023
(Unaudited)
2024
2023
2024
2023
For the three months ended September 30,
For the nine months ended September 30,
2024
2023
2024
2023
Revenue
$ 3,637,000
$ 2,603,000
$ 7,929,000
$ 6,205,000
Cost of revenue
2,377,000
1,690,000
4,991,000
3,963,000
Gross profit
1,260,000
913,000
2,938,000
2,242,000
Operating expenses:
Selling, marketing and distribution
990,000
697,000
2,267,000
1,990,000
General and administrative
705,000
577,000
2,423,000
2,062,000
Depreciation and amortization
65,000
114,000
197,000
310,000
Total operating expenses
1,760,000
1,388,000
4,887,000
4,362,000
Loss from operations
( 500,000 )
( 475,000 )
( 1,949,000 )
( 2,120,000 )
Interest expense
13,000
1,000
24,000
3,000
Net loss
$ ( 513,000 )
$ ( 476,000 )
$ ( 1,973,000 )
$ ( 2,123,000 )
Per share information - basic and fully diluted:
Weighted average shares outstanding
14,744,000
13,036,000
14,655,000
13,005,000
Net loss per share
$ ( 0.03 )
$ ( 0.04 )
$ ( 0.13 )
$ ( 0.16 )
See
the accompanying notes to the condensed consolidated financial statements
4
Barfresh
Food Group Inc.
Consolidated
Statements of Cash Flows
For
the nine months ended September 30, 2024 and 2023
(Unaudited)
2024
2023
Net loss
$ ( 1,973,000 )
$ ( 2,123,000 )
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation
757,000
514,000
Depreciation and amortization
217,000
325,000
Amortization of debt discounts
17,000
-
Stock and options issued for services
-
11,000
Changes in assets and liabilities
Accounts receivable
( 842,000 )
( 1,033,000 )
Other receivables
130,000
( 15,000 )
Inventories
444,000
300,000
Prepaid expenses and other assets
( 95,000 )
( 27,000 )
Accounts payable
( 379,000 )
195,000
Accrued expenses
180,000
( 137,000 )
Net cash used in operating activities
( 1,544,000 )
( 1,990,000 )
Investing activities
Purchase of property and equipment
( 61,000 )
-
Net cash used in investing activities
( 61,000 )
-
Financing activities
Borrowings under line of credit
930,000
-
Repayment of line of credit
( 847,000 )
-
Issuance of convertible debt
65,000
-
Financing agreement payments
( 13,000 )
-
Repurchases from stock compensation program
( 20,000 )
( 18,000 )
Net cash provided by (used in) financing activities
115,000
( 18,000 )
Net decrease in cash
( 1,490,000 )
( 2,008,000 )
Cash, beginning of period
1,891,000
3,019,000
Cash, end of period
$ 401,000
$ 1,011,000
Cash paid during the period for:
Amounts included in the measurement of lease liabilities
$ -
$ 20,000
Non-cash financing and investing activities:
Convertible notes issued in exchange for trade payables
$ 71,000
$ -
Conversion of debt and interest to equity
$ 136,000
$ -
Financed acquisition of long-term assets
$ 245,000
$ -
Value of shares relinquished in modification of stock-based compensations awards
$ -
$ 24,000
See
the accompanying notes to the condensed consolidated financial statements
5
Barfresh
Food Group Inc.
Notes
to Condensed Consolidated Financial Statements
September
30, 2024
(Unaudited)
Note
1. Description of the Business, Basis of Presentation, and Summary of Significant Accounting Policies
Barfresh
Food Group Inc., (“we,” “us,” “our,” and the “Company”) was incorporated on February
25, 2010 in the State of Delaware. The Company is engaged in the manufacturing and distribution of ready-to-drink and ready-to-blend
beverages, particularly, smoothies, shakes and frappes.
Basis
of Presentation
The
accompanying condensed consolidated financial statements are unaudited. These unaudited interim condensed consolidated financial statements
have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and
applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting.
Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been
condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should
be read in conjunction with the audited consolidated financial statements for the fiscal year ended December 31, 2023 included in the
Company’s Annual Report on Form 10-K, as filed with the SEC on March 22, 2024. In management’s opinion, the unaudited interim
condensed consolidated financial statements reflect all adjustments, which are of a normal and recurring nature, that are necessary for
a fair presentation of financial results for the interim periods presented. Operating results for any quarter are not necessarily indicative
of the results for the full fiscal year.
Principles
of Consolidation
The
consolidated financial statements include the financial statements of the Company and our wholly owned subsidiaries, Barfresh Inc. and
Barfresh Corporation Inc. (formerly known as Smoothie, Inc.). All inter-company balances and transactions among the companies have been
eliminated upon consolidation.
Use
of Estimates
The
preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ
from these estimates.
Vendor
Concentrations
The
Company is exposed to supply risk as a result of concentration in its vendor base resulting from the use of a limited number of contract
manufacturers. Purchases from the Company’s significant contract manufacturers as a percentage of all finished goods purchased
were as follows:
Schedule
of Contract Manufacturers Percentage of Finished Goods
2024
2023
2024
2023
For the three months ended September 30,
For the nine months ended September 30,
2024
2023
2024
2023
Manufacturer A
63 %
55 %
58 %
47 %
Manufacturer B
37 %
37 %
40 %
44 %
Manufacturer C
0 %
8 %
2 %
9 %
Concentration risk percentage
100 %
100 %
100 %
100 %
6
Summary
of Significant Accounting Policies
There
have been no changes to our significant accounting policies described in our Annual Report on Form 10-K for the year ended December 31,
2023, as filed with the SEC on March 22, 2024 that have had a material impact on our condensed consolidated financial statements and
related notes.
Financial
Instruments
The
Company’s financial instruments consist of cash, accounts receivable, accounts payable, the line of credit and financing agreements. The carrying value of the Company’s
financial instruments approximates their fair value.
Accounts
Receivable and Allowances
Accounts
receivable are recorded and carried at the original invoiced amount less allowances for credits and for any potential uncollectible amounts
due to credit losses. We make estimates of the expected credit and collectability trends for the allowance for credit losses based on
our assessment of various factors, including historical experience, the age of the accounts receivable balances, credit quality of our
customers, current economic conditions, and other factors that may affect our ability to collect from our customers. Expected credit
losses are recorded as general and administrative expenses on our condensed consolidated statements of operations. As of September 30,
2024 and December 31, 2023, there was no allowance for credit losses. There was no credit loss expense for the three and nine months
ended September 30, 2024 and 2023.
Other
Receivables
Other
receivables consist of the Company’s 2021 Employee Retention Tax Credit “ERTC” claim, which the Company collected
in March 2024, amounts due from vendors for materials acquired on their behalf for use in manufacturing the Company’s
products, vendor rebates and freight claims.
ERTC
claims can be made in a variety of circumstances with varying degrees of subjectivity and clear authoritative guidance. Paid claims are
subject to IRS inspection which may occur prior to expiration of the statute of limitations. The Company’s ERTC claim was based
on objectively calculated declines in revenue using methods that are clearly defined in the Coronavirus Aid, Relief, and Economic Security
Act and various regulations and interpretations thereof.
Revenue
Recognition
In
accordance with ASC 606, Revenue from Contracts with Customers, revenue is recognized when a customer obtains ownership of promised goods.
The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these
goods. The Company applies the following five steps:
1)
Identify
the contract with a customer
A
contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s
rights, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration
for goods or services that are transferred is probable. For the Company, the contract is the approved sales order, which may also
be supplemented by other agreements that formalize various terms and conditions with customers.
2)
Identify
the performance obligation in the contract
Performance
obligations promised in a contract are identified based on the goods or services that will be transferred to the customer. For the
Company, this consists of the delivery of frozen beverages, which provide immediate benefit to the customer.
3)
Determine
the transaction price
The
transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring goods
and is generally stated on the approved sales order. Variable consideration, which typically includes rebates or discounts, are estimated
utilizing the most likely amount method. Provisions for refunds are generally provided for in the period the related sales are recorded,
based on management’s assessment of historical and projected trends.
7
4)
Allocate
the transaction price to performance obligations in the contract
Since
the Company’s contracts contain a single performance obligation, delivery of frozen beverages, the transaction price is allocated
to that single performance obligation.
5)
Recognize
revenue when or as the Company satisfies a performance obligation
The
Company recognizes revenue from the sale of frozen beverages when title and risk of loss passes and the customer accepts the goods,
which generally occurs at the time of delivery to a customer warehouse. Customer sales incentives such as volume-based rebates or
discounts are treated as a reduction of sales at the time the sale is recognized. Shipping and handling costs are treated as fulfilment
costs and presented in distribution, selling and administrative costs.
Payments
that are received before performance obligations are recorded are shown as current liabilities.
The
Company evaluated the requirement to disaggregate revenue and concluded that substantially all of its revenue comes from a single
product, frozen beverages.
Storage
and Shipping Costs
Storage
and outbound freight costs are included in selling, marketing and distribution expense. For the three months ending September 30, 2024
and 2023, storage and outbound freight totaled approximately $ 480,000 and $ 370,000 , respectively. For the nine months ended September
30, 2024 and 2023, storage and outbound freight totaled approximately $ 1,061,000 and $ 932,000 , respectively.
Research
and Development
Expenditures
for research activities relating to product development and improvement are charged to expense as incurred. The Company incurred approximately
$ 52,000 and $ 32,000 in research and development expense for the three months ended September 30, 2024 and 2023, respectively, and $ 99,000
and $ 88,000 for the nine months ended September 30, 2024 and 2023, respectively.
Loss
Per Share
For
the three and nine months ended September 30, 2024 and 2023, common stock equivalents have not been included in the calculation of net
loss per share as their effect is anti-dilutive as a result of losses incurred.
Reclassifications
Certain
reclassifications have been made to the 2023 financial statements to conform to the 2024 presentation, namely stock-based compensation
paid to the Company’s directors has been reclassified from stock and options issued for services and shares repurchased for employee
tax withholding under the Company’s stock compensation program have been reclassified to financing activities in the consolidated
statement of cash flows, with corresponding changes reflected in the statement of stockholders’ equity for the nine months ended
September 30, 2023.
Recent
Pronouncements
From
time to time, new accounting pronouncements are issued that we adopt as of the specified effective date. We have not determined if the
impact of recently issued standards that are not yet effective will have an impact on our results of operations and financial position.
8
Note
2. Inventory
Inventory
consists of the following:
Schedule of Inventory
September 30,
December 31,
2024
2023
Raw materials and packaging
$ 335,000
$ 28,000
Finished goods
435,000
1,186,000
Inventory, net
$ 770,000
$ 1,214,000
Note
3. Property Plant and Equipment
Property
and equipment, net consist of the following:
Schedule of Property and Equipment, Net
September 30,
December 31,
2024
2023
Manufacturing equipment
$ 1,548,000
$ 1,546,000
Customer equipment
1,402,000
1,410,000
Construction in progress
145,000
-
Property and equipment, gross
3,095,000
2,956,000
Less: accumulated depreciation
( 2,705,000 )
( 2,547,000 )
Property and equipment, net of depreciation
$ 390,000
$ 409,000
Depreciation
expense related to these assets was approximately $ 55,000 and $ 102,000 for the three months ended September 30, 2024 and 2023, respectively,
and $ 168,000 and $ 277,000 for the nine months ended September 30, 2024 and 2023, respectively. Depreciation expense in cost of revenue
was $ 6,000 and $ 4,000 for the three months ended September 30, 2024 and 2023, respectively, and $ 19,000 and $ 13,000 for the nine months
ended September 30, 2024 and 2023, respectively.
Note
4. Commitments and Contingencies
Lease
Commitments
The
Company leases office space under a non-cancellable operating lease which expired on March 31, 2023 , and was extended in a series of
amendments through March 31, 2025 . The Company’s periodic lease cost was approximately $ 20,000 for each of the three month periods
ended September 30, 2024 and 2023 and $ 60,000 for each of the nine month periods ended September 30, 2024 and 2023.
Legal
Proceedings
Schreiber
Dispute
The
Company’s products are produced to its specifications through several contract manufacturers. One of the Company’s contract
manufacturers (the “Manufacturer”) provided approximately 52 % and 42 % of the Company’s products in the years ended
December 31, 2022 and 2021, respectively, under a Supply Agreement with an initial term through September 2025.
Over
the course of 2022, the Company experienced numerous quality issues with the case packaging utilized by the Manufacturer. In addition,
in July of 2022, the Company began receiving customer complaints about the texture of the Company’s smoothie products produced
by the Manufacturer. In response, the Company withdrew product from the market and destroyed on-hand inventory, withholding $ 499,000
in payments due to the Manufacturer.
9
The
Company attempted to resolve the issues based on the contractual procedures described in the Supply Agreement. However, on November 4,
2022, in response to a formal proposal of alternate resolutions, the Company received notification from the Manufacturer that it was
denying any responsibility for the defective manufacture of the product. In response, on November 10, 2022, the Company filed a complaint
in the United States District Court for the Central District of California, Western Division (the “Complaint”), claiming
that the Manufacturer had not met its obligations under the Supply Agreement, and seeking economic damages. In response, the Manufacturer
terminated the Supply Agreement. On January 20, 2023, the Company filed a voluntary dismissal of the Complaint which allowed the parties
to reach a potential resolution outside of the court system. However, as the parties were once again unable to come to an agreement,
the Company re-filed the Complaint in California State Court in August 2023 and continues to progress through the court system.
In
May 2024, the Company entered into a non-recourse litigation financing arrangement which is expected to be adequate to pursue the Complaint
to conclusion.
Due
to the uncertainties surrounding the claim, the Company is not able to predict either the outcome or a range of reasonably possible recoveries
that could result from its actions against the Manufacturer, and no gain contingencies have been recorded. The disruption in its supply
resulting from the dispute has and will continue to adversely impact the Company’s results of operations and cash flow until a
suitable resolution is reached or new sources of reliable supply at sufficient volume can be identified and developed, the timing of
which is uncertain. The Company has mitigated the impact of the supply disruption with the introduction of its single-serve smoothie
cartons; however the product format has not been accepted by some customers or as a substitute for the bottle product in all use cases.
Other
Legal Matters
From
time to time, various lawsuits and legal proceedings may arise in the ordinary course of business. However, litigation is subject to
inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are
currently the defendant in one legal proceeding for an amount less than $ 100,000 . Our legal counsel and management believe the probability
of a material unfavorable outcome is remote.
Note
5. Debt
Line
of Credit
In
August 2024, the Company secured receivables financing of $ 1,500,000 (the “Facility”). Under the Facility,
the Company may borrow up to 90% of eligible customer account balances. Amounts outstanding bear interest at a rate prime plus 1.2% (9.20%
as of September 30, 2024) and collateral fees of 0.15% and are secured by accounts receivable and inventory. The Facility terminates on September 5, 2025, and renews automatically,
unless notice is given or received. As of September 30, 2024, borrowings under the Facility amounted to $ 86,000 , net of unamortized
deferred financing cost of $ 14,000 , and $ 1,400,000 was available to borrow.
Financing
Agreements
In
2024, the Company entered into financing agreements to purchase equipment and software as a service, with imputed or stated interest
of 15 - 19 %. Amounts due under the agreements are as follows as of September 30, 2024:
Schedule
of Financing Agreements
2024 (3 months)
$ 32,000
2025
129,000
2026
136,000
Total payments due
297,000
Less: interest
( 51,000 )
Financing agreements
246,000
Less: current portion
( 95,000 )
Financing agreements
$ 151,000
10
Convertible
Notes
From
July 2023 to March 2024, the Company executed subscription agreements for substantially all of a $ 2,000,000 privately placed convertible
debt offering. The debt was available to be drawn in 25% increments, maturing on the anniversary of the draw, bearing interest at 10%
per annum for the term, regardless of earlier payment or conversion, and was mandatorily convertible as to principal and interest into
shares of the Company’s common stock at any time prior to maturity at the greater of $1.20 or 85% of the volume-weighted average
price of the common stock for the ten trading days immediately preceding the written notice of the conversion (the “Conversion
Price”). If the Company had not exercised the mandatory conversion, the holder of the debt had the option after six months and
on up to four occasions to convert all or any portion of the principal and interest into shares of the Company’s common stock at
the Conversion Price .
On
October 23, 2023, the Company drew down $ 1,390,000 in convertible debt and converted a total of $ 1,207,000 of principal into 820,160
shares of common stock. Additionally, on December 19, 2023, the Company drew down $ 470,000 in convertible debt and converted a total
of $ 653,000 of principal and $ 4,000 of accrued interest into 495,331 shares of common stock. Finally, on March 27 and 29, 2024 the Company
drew down $ 136,000 in convertible debt and converted the total drawn into 124,208 shares, settling all debt. Debt drawdowns included
the non-cash settlement of $ 30,000 and $ 71,000 in 2023 and 2024, respectively.
Note
6. Stockholders’ Equity
The
following are changes in stockholders’ equity for the nine months ended September 30, 2023 and 2024:
Schedule of Changes in Stockholders' Equity
Additional
Common Stock
paid in
Accumulated
Shares
Amount
Capital
(Deficit)
Total
Balance December 31, 2022
12,934,741
$ -
$ 60,905,000
$ ( 57,972,000 )
$ 2,933,000
Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding
165,779
-
( 18,000 )
-
( 18,000 )
Equity-based compensation expense
-
-
514,000
-
514,000
Cash settlement of equity-based compensation
-
-
( 24,000 )
-
( 24,000 )
Issuance of stock for services
4,094
-
11,000
-
11,000
Net loss
-
-
-
( 2,123,000 )
( 2,123,000 )
Balance September 30, 2023
13,104,614
$ -
$ 61,388,000
$ ( 60,095,000 )
$ 1,293,000
Additional
Common Stock
paid in
Accumulated
Shares
Amount
Capital
(Deficit)
Total
Balance December 31, 2023
14,420,105
$ -
$ 63,299,000
$ ( 60,796,000 )
$ 2,503,000
Balance
14,420,105
$ -
$ 63,299,000
$ ( 60,796,000 )
$ 2,503,000
Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding
201,859
-
( 20,000 )
-
( 20,000 )
Equity-based compensation expense
-
-
757,000
-
757,000
Conversion of debt and interest (Note 5)
124,208
-
136,000
-
136,000
Net loss
-
-
-
( 1,973,000 )
( 1,973,000 )
Balance September 30, 2024
14,746,172
$ -
$ 64,172,000
$ ( 62,769,000 )
$ 1,403,000
Balance
14,746,172
$ -
$ 64,172,000
$ ( 62,769,000 )
$ 1,403,000
Warrants
During
the nine months ended September 30, 2024, 122,739 warrants at a weighted average exercise price of $ 9.10 per share expired.
Equity
Incentive Plan
Through
2022, the Company issued equity awards under the 2015 Equity Incentive Plan (the “2015 Plan”) and outside the Plan. In June
2023, the Company’s stockholders adopted the 2023 Equity Incentive Plan (the “2023 Plan”), reserving 650,000 shares
for future issuance. The Board of Directors discontinued further grants under the 2015 Plan. In March 2024, the Board of Directors amended
the 2023 Plan to reserve an additional 650,000 shares for future issuance, bringing the total for the plan to 1,300,000 , and to provide
an evergreen provision that reserves additional shares depending on future non-plan issuances of common stock.
As
of September 30, 2024, the Company has $ 545,000 of total unrecognized share-based compensation expense relative to unvested options,
stock awards and stock units, which is expected to be recognized over the remaining weighted average period of 2.8 years.
11
Stock
Options
The
following is a summary of stock option activity for the nine months ended September 30, 2024:
Schedule of Stock Options Activity
Number of Options
Weighted average exercise price per share
Remaining term in years
Outstanding on December 31, 2023
587,091
$ 6.50
3.6
Issued
238,482
$ 2.05
8.0
Expired
( 71,930 )
$ 7.95
Outstanding on September 30, 2024
753,643
$ 4.95
5.3
Exercisable, September 30, 2024
540,681
$ 5.98
3.8
The
fair value of the options issued was calculated using the Black-Scholes option pricing model, based on the following:
Schedule
of Fair Value of Options Using Black-Sholes Option Pricing Model
2024
Expected term (in years)
8.0
Expected volatility
93.5 %
Risk-free interest rate
4.2 %
Expected dividends
$ -
Weighted average grant date fair value per share
$ 1.77
Restricted
Stock
The
following is a summary of restricted stock award and restricted stock unit activity for the nine months ended September 30, 2024:
Schedule of Restricted Stock Award and Restricted Stock Unit Activity
Number of shares
Weighted average grant date fair value
Unvested at January 1, 2024
32,606
$ 4.82
Granted
65,000
$ 1.73
Vested
( 10,733 )
$ 5.58
Unvested at September 30, 2024
86,873
$ 2.41
Performance
Share Units
During
2023 and 2024, the Company issued performance share units (“PSUs”) that represented shares potentially issuable based upon
Company and individual performance in the years of issuance.
The
following table summarizes the activity for the Company’s unvested PSUs for the nine months ended September 30, 2024:
Schedule of Performance Stock Unit Activity
Number of shares
Weighted average grant date fair value
Unvested at January 1, 2024
63,888
$ 1.70
Granted
429,844
$ 1.22
Vested
( 55,217 )
$ 1.15
Unvested and expected to vest at September 30, 2024
438,515
$ 1.20
12
In
February 2023, the unvested awards issued and outstanding for individual performance under the 2022 PSU program were modified to cash-settle
the original grant-date fair value of approximately $ 80,000 , resulting in incremental compensation of $ 56,000 after considering the $ 24,000
fair value of the vested shares at the date of the modification. Additionally, the Company performance targets were modified to allow
approximately 71,000 PSUs to vest, with an additional time-based vesting requirement for approximately 26,000 of the PSUs. Because the
awards did not vest based on the original terms, the modification was considered a new grant, resulting in $ 64,000 in compensation expense
in the nine months ended September 30, 2023.
The
Company adopted a 2024 PSU program in March 2024, granting approximately 430,000 PSUs at target performance against company-wide and
individual performance metrics. The results for the three and nine months ended September 30, 2024 include $ 79,000 and $ 289,000 , respectively,
in expense for the 2024 PSU program. Estimates of expense associated with 2024 performance will be reassessed each quarter through the
performance period.
Note
7. Income Taxes
ASC
740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of evidence, it is more than likely
than not that some portion or all the deferred tax assets will not be recognized. Accordingly, at this time the Company has placed a
valuation allowance on all tax assets. As of September 30, 2024, the estimated effective tax rate for 2024 was zero .
There
are open statutes of limitations for taxing authorities in federal and state jurisdictions to audit our tax returns from 2018 through
the current period. Our policy is to account for income tax related interest and penalties in income tax expense in the statement of
operations.
For
the three and nine months ended September 30, 2024 and 2023, the Company did not incur any interest and penalties associated with tax
positions. As of September 30, 2024, the Company did not have any significant unrecognized uncertain tax positions.
Note
8. Liquidity
During
the nine months ended September 30, 2024, the Company used $ 1,544,000 in operations. As of September 30, 2024, the Company had $ 1,371,000
of working capital, including $ 401,000 in cash and excluding $ 499,000 in disputed co-manufacturer accounts payable (Note 4).
The
Company has a history of negative cash flow and operating losses, which were expected to improve with growth. As described more fully
in Note 4, the dispute and subsequent contract termination with the Manufacturer has resulted in limitations in the Company’s ability
to procure certain products necessary to achieve our growth projections and in elevated legal costs.
To
mitigate the impact of procurement constraints, the Company built and paid for inventory in anticipation of third quarter seasonal requirements,
contributing $ 320,000 to the cash used in operations in the first half of 2024. The inventory build allowed the Company to generate a
40 % increase in revenue in the three months ended September 30, 2024 compared to the prior year quarter. Accounts receivable increased
with revenue by $ 504,000 compared with September 30, 2023. The Company secured a receivables-based line of credit in August 2024 of $ 1,500,000 ,
with $ 1,400,000 available to borrow as of September 30, 2024. Management expects that the cash cycle will shorten as additional contracted
capacity commences production in the fourth quarter of 2024, offset by additional working capital necessary for further anticipated growth.
Additionally, in May 2024, the Company obtained non-recourse litigation financing to allow vigorous pursuit of the complaint against
the Manufacturer without further expense to the Company.
Although
alleviated, the financial position at September 30, 2024 and historical results raise substantial doubt about the Company’s ability
to continue as a going concern. As described, the Company has taken and partially completed steps to mitigate the dispute related issues.
Management believes that other potential actions are feasible, including raising additional financing and reducing growth-related expenditures.
While management cannot predict with certainty whether additional actions would achieve the predicted outcome, the availability of such
options, along with the actions already taken, resulted in the alleviation of the substantial doubt about the Company’s ability
to continue as a going concern.
13
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.